TP53 and Alzheimer disease: Another shortcoming of this study was that the effect of cx-5461 on p53-/- AD mice could not be evaluated due to the extremely low proportion (2-3%) of the p53-/- offspring produced by crossing p53+/- mice, a phenomenon consistent with Jackson Laboratory's description.